Tags: novo dordisk | obesity | drug

Novo Nordisk: New Obesity Drugs May Justify Higher Prices

Novo Nordisk: New Obesity Drugs May Justify Higher Prices
French President Emmanuel Macron, right, speaks with CEO of Novo Nordisk Lars Fruergaard Jorgensen during the 6th edition of the "Choose France" Summit at the Chateau de Versailles, outside Paris. (Ludovic Marin/Getty Images/2023 file photo)

Friday, 08 March 2024 06:53 AM EST

Novo Nordisk's CEO expects more people to take obesity drugs as prices fall over time, he told Reuters Friday, adding that new generations of the medicine will justify higher prices in some segments.

"I expect that over time we'll see a lower price point that will cater for more and more patients getting on treatment," CEO Lars Fruergaard Jorgensen said in an interview.

Novo's shares rose to new record highs on Thursday after the company announced early trial data for an experimental obesity drug, amycretin.

"You will see new generations of innovations that will cater for even more differentiation, perhaps serve certain comorbidities better, and that can justify a higher price in some segments," Jorgensen said.

© 2024 Thomson/Reuters. All rights reserved.


StreetTalk
Novo Nordisk's CEO expects more people to take obesity drugs as prices fall over time, he told Reuters Friday, adding that new generations of the medicine will justify higher prices in some segments.
novo dordisk, obesity, drug
116
2024-53-08
Friday, 08 March 2024 06:53 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved